Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
4.290
+0.190 (4.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
Xenetic Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2.52 | 2.54 | 1.71 | 1.16 | 0.44 | 0.02 | Upgrade
|
| Revenue Growth (YoY) | 7.15% | 48.80% | 47.06% | 165.64% | 2460.31% | - | Upgrade
|
| Gross Profit | 2.52 | 2.54 | 1.71 | 1.16 | 0.44 | 0.02 | Upgrade
|
| Selling, General & Admin | 3.66 | 3.56 | 3.65 | 3.74 | 3.4 | 3.63 | Upgrade
|
| Research & Development | 3.22 | 3.49 | 4.77 | 3.16 | 1.73 | 4.89 | Upgrade
|
| Operating Expenses | 6.88 | 7.06 | 8.42 | 6.91 | 5.13 | 8.52 | Upgrade
|
| Operating Income | -4.36 | -4.52 | -6.72 | -5.75 | -4.69 | -8.5 | Upgrade
|
| Interest & Investment Income | 0.28 | 0.36 | 0.17 | 0.1 | 0.13 | 0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0.03 | -0 | 0 | -0 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -4.08 | -4.13 | -6.55 | -5.65 | -4.57 | -8.39 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -1.1 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -3.28 | Upgrade
|
| Asset Writedown | - | - | - | - | -9.24 | - | Upgrade
|
| Pretax Income | -4.08 | -4.13 | -6.55 | -5.65 | -13.81 | -12.78 | Upgrade
|
| Income Tax Expense | - | - | - | - | -2.92 | - | Upgrade
|
| Net Income | -4.08 | -4.13 | -6.55 | -5.65 | -10.89 | -12.78 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 5.28 | Upgrade
|
| Net Income to Common | -4.08 | -4.13 | -6.55 | -5.65 | -10.89 | -18.06 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 1.34% | 7.44% | 38.38% | 60.81% | 124.10% | 277.30% | Upgrade
|
| EPS (Basic) | -2.65 | -2.71 | -4.61 | -5.49 | -17.04 | -63.31 | Upgrade
|
| EPS (Diluted) | -2.65 | -2.71 | -4.61 | -5.49 | -17.04 | -63.31 | Upgrade
|
| Free Cash Flow | -2.94 | -4.11 | -4.65 | -4.74 | -4.27 | -6.4 | Upgrade
|
| Free Cash Flow Per Share | -1.91 | -2.69 | -3.27 | -4.61 | -6.68 | -22.43 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -172.82% | -177.79% | -393.57% | -495.12% | -1074.41% | -49826.85% | Upgrade
|
| Profit Margin | -161.58% | -162.78% | -383.87% | -486.36% | -2493.11% | -105820.95% | Upgrade
|
| Free Cash Flow Margin | -116.37% | -161.98% | -272.23% | -408.21% | -976.60% | -37497.97% | Upgrade
|
| EBITDA | - | - | - | -5.75 | -4.69 | -8.5 | Upgrade
|
| D&A For EBITDA | - | - | - | 0 | 0 | 0 | Upgrade
|
| EBIT | -4.36 | -4.52 | -6.72 | -5.75 | -4.69 | -8.5 | Upgrade
|
| EBIT Margin | -172.82% | -177.78% | - | - | - | - | Upgrade
|
| Revenue as Reported | 2.52 | 2.54 | 1.71 | 1.16 | 0.44 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.